New Therapy for Type 1 Diabetes

This is a the United States news story, published by ABC News, that relates primarily to Marlaina Goedel news.

the United States news

For more the United States news, you can click here:

more the United States news

Marlaina Goedel news

For more Marlaina Goedel news, you can click here:

more Marlaina Goedel news

medical innovations news

For more medical innovations news, you can click here:

more medical innovations news

ABC News news

For more news from ABC News, you can click here:

more news from ABC News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about

diabetic attack

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diabetes impacts news, diabetic ketoacidosis news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

diabetes

ABC News

•

New therapy after islet cell transplant shows promise for people with Type 1 diabetes

Summary

Nutrition label

80% Informative

New therapy after islet cell transplant shows promise for people with Type 1 diabetes.

Marlaina Goedel , who was diagnosed with diabetes at age 5 , said she is no longer on insulin.

Dr. Daniel Gilada , a husband, physician and soon-to-be father of four , said living with diabetes had become "overwhelming" New data from a clinical trial showed early signs of success in the first three patients.

The function of the transplant was three to five times higher than three subjects who received tacrolimus-based immunosuppression.

Researchers say the new therapy may be less toxic to the transplanted islets as hoped, resulting in improved graft survival and function.

The researchers say they face regulatory barriers in the United States that prevent more people from receiving islet cell transplants.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language